Tuvirumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Tuvirumab
Monoclonal antibody
Type ?
Source Human
Target hepatitis B virus
Clinical data
ATC code
  • none
Identifiers
ChemSpider
  • none
  (verify)

Tuvirumab is a human monoclonal antibody for the treatment of patients with chronic hepatitis B. It has undergone Phase I clinical trials in 2001.[1][2]

References[edit]

  1. ^ Heijtink, RA; Van Nunen, AB; Van Bergen, P; Ostberg, L; Osterhaus, AD; De Man, RA (2001). "Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: monitoring of serum TUVIRUMAB in immune complexes". Journal of medical virology. 64 (4): 427–34. PMID 11468726. doi:10.1002/jmv.1068. 
  2. ^ Van Nunen, AB; Baumann, M; Manns, MP; Reichen, J; Spengler, U; Marschner, JP; De Man, RA; International Study, Group (2001). "Efficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patients". Liver. 21 (3): 207–12. PMID 11422784. doi:10.1034/j.1600-0676.2001.021003207.x.